Learn more

UNIVERZITA PALACKUHO V OLOMOUCI

Overview
  • Total Patents
    14
About

UNIVERZITA PALACKUHO V OLOMOUCI has a total of 14 patent applications. Its first patent ever was published in 2007. It filed its patents most often in Czechia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and basic materials chemistry are PLIVA-ISTRAŽIVAEKI INSTITUT D.O.O., CARUSO MICHELE and PLIVA D D.

Patent filings in countries

World map showing UNIVERZITA PALACKUHO V OLOMOUCIs patent filings in countries
# Country Total Patents
#1 Czechia 14

Patent filings per year

Chart showing UNIVERZITA PALACKUHO V OLOMOUCIs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Strnad Miroslav 6
#2 Zatloukal Marek 5
#3 Dolezal Karel 5
#4 Zboril Radek 3
#5 Krystof Vladimir 3
#6 Hlavac Jan 2
#7 Hradil Pavel 2
#8 Spichal Lukas 2
#9 Soural Miroslav 2
#10 Havlicek Libor 2

Latest patents

Publication Filing date Title
CZ303502B6 Immobilization method of silver nanoparticles to solid substrates
CZ2010898A3 Process for preparing aqueous dispersions of metal nanoparticles
CZ2010670A3 Use of 6-substituted 9-haloalkyl purines for regulating growth and development of plants, vegetable organs and cells, and novel 6-substituted 9-haloalkyl purines
CZ2010612A3 Use of ultra small iron particles for disposal, prevention or restriction of mass development of cyanobacterium water blooms
CZ2010380A3 Mossbauer spectrometer
CZ2010332A3 Substitution derivatives of N6-benzyladenosine-5?-monophosphate, methods of their preparation, their use for preparation of s medicament and therapeutic composition containing thereof
CZ302510B6 Efficient method of biotinylation of compounds containing carboxyl group using solid phase synthesis for affinity chromatography needs
CZ302669B6 Efficient method of biotinylation of amino compounds using solid phase synthesis for affinity chromatography needs
CZ2009359A3 Substituted 6-(2-hydroxybenzylamino)purine derivatives, their use as medicaments and pharmaceutical compositions comprising thereof
CZ2009298A3 Substituted 6-benzylaminopurine ribosides, their use and pharmaceutical composition in which said compounds are comprised
CZ200945A3 Substituted derivatives of 6-(2-aminobenzylamino)purine, their use as well as a medicament and compositions in which said derivatives are comprised
CZ200840A3 Method of determining sensitivity of patients with tumorous disease to treatment with HER-2 receptor inhibitors
CZ2007453A3 Substituted 6-anilinopurine derivatives functioning as cytokine oxidase inhibitors and formulations containing such compounds
CZ2007255A3 Synthesis method of nanopowder iron with protective oxidic shell from natural abd synthetic nanopowder iron oxides and oxihydroxides